Advanced Search
Contact | Corporate | Help

Rituximab, Fludarabine, Mitoxantrone, Dexamethasone (R-FND) Plus Zevalin for High-Risk Follicular Lymphoma

Sponsors:
  • M.D. Anderson Cancer Center
  • Genentech
  • Biogen Idec
Phases:
  • Phase II
IndicationsAcronym:
  • Lymphoma
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: Fludarabine
  • Drug: Mitoxantrone
  • Drug: Rituximab
  • Drug: Zevalin
  • Drug: Dexamethasone
Enrollment:
50

Additional information about NCT00290511.


SourceSolution © 2008-2012